574 research outputs found

    Transition-State Interactions in a Promiscuous Enzyme: Sulfate and Phosphate Monoester Hydrolysis by Pseudomonas aeruginosa Arylsulfatase.

    Get PDF
    Pseudomonas aeruginosa arylsulfatase (PAS) hydrolyzes sulfate and, promiscuously, phosphate monoesters. Enzyme-catalyzed sulfate transfer is crucial to a wide variety of biological processes, but detailed studies of the mechanistic contributions to its catalysis are lacking. We present linear free energy relationships (LFERs) and kinetic isotope effects (KIEs) of PAS and analyses of active site mutants that suggest a key role for leaving group (LG) stabilization. In LFERs PASWT has a much less negative BrĂžnsted coefficient (ÎČleaving groupobs-Enz = -0.33) than the uncatalyzed reaction (ÎČleaving groupobs = -1.81). This situation is diminished when cationic active site groups are exchanged for alanine. The considerable degree of bond breaking during the transition state (TS) is evidenced by an 18Obridge KIE of 1.0088. LFER and KIE data for several active site mutants point to leaving group stabilization by active site K375, in cooperation with H211. 15N KIEs and the increased sensitivity to leaving group ability of the sulfatase activity in neat D2O (ΔÎČleaving groupH-D = +0.06) suggest that the mechanism for S-Obridge bond fission shifts, with decreasing leaving group ability, from charge compensation via Lewis acid interactions toward direct proton donation. 18Ononbridge KIEs indicate that the TS for PAS-catalyzed sulfate monoester hydrolysis has a significantly more associative character compared to the uncatalyzed reaction, while PAS-catalyzed phosphate monoester hydrolysis does not show this shift. This difference in enzyme-catalyzed TSs appears to be the major factor favoring specificity toward sulfate over phosphate esters by this promiscuous hydrolase, since other features are either too similar (uncatalyzed TS) or inherently favor phosphate (charge).BBSRC BB/I004327/1 EPSRC EP/E019390/1

    A guide to qualitative haze measurements demonstrated on inkjet-printed silver electrodes for flexible OLEDs

    Get PDF
    The search for alternative transparent electrodes to the commonly used indium tin oxide (ITO) in optoelectronic devices has led to solution-based approaches based on inkjet printing. As an additive manufacturing technique that allows drops to be positioned only where necessary, inkjet printing shows reduced waste of starting material compared to other methods such as spin coating. As a result, functional materials can be both coated and structured without the need for masks or lithographic pre-patterning of the substrate. For this contribution, we utilized a particle-free silver ink to produce a transparent electrode by inkjet printing. After printing, the silver ions were reduced to metallic silver by an argon plasma. The process takes place at low temperatures (ca. 40 – 50°C), making it suitable for use with flexible substrates, which are often temperature-sensitive. The printed silver layers show good electrical conductivity and optical transmittance, with a crystalline grain structure being formed and maintained during the metallization process. This structure forms a self-organized nanometer-size grid, whose structure allows light to pass through. Due to its nano-structured property, the haze of the electrode was investigated using a simple experimental setup based on a light source shining through the electrode and analyzing the size of the projected pattern. Such qualitative assessment can be a useful indication of the quality of the electrode and we provide details on how to replicate this setup. The final electrodes were implemented in solution-processed OLEDs, which showed bright luminance and overall low haze compared to ITO-based reference devices.Peer Reviewe

    ITO free OLEDs utilizing inkjet printed and low temperature plasma sintered Ag electrodes

    Get PDF
    We report an inkjet printed indium tin oxide ITO free electrode made from a particle free silver ink. After printing, an argon plasma is used to reduce the silver ions in the ink to metallic silver. This process does not require high temperatures and is therefore suitable for use with temperature sensitive substrates. Printed silver layers show good optical transmittance and electrical conductivity. To demonstrate the capabilities of the electrodes, inverted ITO free organic light emitting diodes OLEDs were produced via solution processing. In terms of luminance and efficacy, the devices containing the printed electrodes show improved luminance and current efficacy compared to ITO based reference devices. When fabricated with flexible substrates, the printed OLEDs show high bending stability, enabling flexible application

    Sample cartridge with built in miniature molecule evaporator for in situ measurement with a photoemission electron microscope

    Get PDF
    We present a new sample holder that is compatible with Photoemission Electron Microscopes PEEMs and contains a molecule evaporator. With the integrated low cost evaporator, a local and controlled material deposition in clean ultra high vacuum conditions can be achieved minimizing the contamination of the analysis chamber. Different molecule systems can easily be studied by exchanging the sample holder. This opens up new possibilities for in situ investigation of thin film growth by means of spectromicroscopy and element selective imaging at the nanometer scale. As an example of the performances of the setup, we present a study of the hybrid inorganic organic system HIOS consisting of the organic acceptor molecule 2,2 amp; 8242; perfluoronaphthalene 2,6 diylidene dimalononitrile F6TCNNQ and ZnO, which is of great interest for novel HIOS based optoelectronic devices. Here, the ZnO surface work function modification by F6TCNNQ adsorption is investigated in situ in a spatially resolved manner. In addition, we employ PEEM to selectively probe the chemical state of F6TCNNQ molecules in contact with ZnO in the first monolayer and those molecules located in multilayers in 3D island

    Septicemia Caused by Tick-borne Bacterial Pathogen Candidatus Neoehrlichia mikurensis

    Get PDF
    We have repeatedly detected Candidatus Neoehrlichia mikurensis, a bacterium first described in Rattus norvegicus rats and Ixodes ovatus ticks in Japan in 2004 in the blood of a 61-year-old man with signs of septicemia by 16S rRNA and groEL gene PCR. After 6 weeks of therapy with doxycycline and rifampin, the patient recovered

    Gene clusters reflecting macrodomain structure respond to nucleoid perturbations

    Full text link
    Focusing on the DNA-bridging nucleoid proteins Fis and H-NS, and integrating several independent experimental and bioinformatic data sources, we investigate the links between chromosomal spatial organization and global transcriptional regulation. By means of a novel multi-scale spatial aggregation analysis, we uncover the existence of contiguous clusters of nucleoid-perturbation sensitive genes along the genome, whose expression is affected by a combination of topological DNA state and nucleoid-shaping protein occupancy. The clusters correlate well with the macrodomain structure of the genome. The most significant of them lay symmetrically at the edges of the ter macrodomain and involve all of the flagellar and chemotaxis machinery, in addition to key regulators of biofilm formation, suggesting that the regulation of the physical state of the chromosome by the nucleoid proteins plays an important role in coordinating the transcriptional response leading to the switch between a motile and a biofilm lifestyle.Comment: Article: first 24 pages, 3 figures Supplementary methods: 1 page, 1 figure Supplementary results: 14 pages, 11 figure

    Novel cyclic di-GMP effectors of the YajQ protein family control bacterial virulence

    Get PDF
    Bis-(3 ',5 ') cyclic di-guanylate (cyclic di-GMP) is a key bacterial second messenger that is implicated in the regulation of many critical processes that include motility, biofilm formation and virulence. Cyclic di-GMP influences diverse functions through interaction with a range of effectors. Our knowledge of these effectors and their different regulatory actions is far from complete, however. Here we have used an affinity pull-down assay using cyclic di-GMP-coupled magnetic beads to identify cyclic di-GMP binding proteins in the plant pathogen Xanthomonas campestris pv. campestris (Xcc). This analysis identified XC_3703, a protein of the YajQ family, as a potential cyclic di-GMP receptor. Isothermal titration calorimetry showed that the purified XC_3703 protein bound cyclic di-GMP with a high affinity (K-d similar to 2 mu M). Mutation of XC_3703 led to reduced virulence of Xcc to plants and alteration in biofilm formation. Yeast two-hybrid and far-western analyses showed that XC_3703 was able to interact with XC_2801, a transcription factor of the LysR family. Mutation of XC_2801 and XC_3703 had partially overlapping effects on the transcriptome of Xcc, and both affected virulence. Electromobility shift assays showed that XC_3703 positively affected the binding of XC_2801 to the promoters of target virulence genes, an effect that was reversed by cyclic di-GMP. Genetic and functional analysis of YajQ family members from the human pathogens Pseudomonas aeruginosa and Stenotrophomonas maltophilia showed that they also specifically bound cyclic di-GMP and contributed to virulence in model systems. The findings thus identify a new class of cyclic di-GMP effector that regulates bacterial virulence

    Interleukin-2 therapy in patients with HIV infection

    Get PDF
    BACKGROUND Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known. METHODS We conducted two trials: the Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts under Active Antiretroviral Therapy (SILCAAT) study and the Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT). In each, patients infected with the human immunodeficiency virus (HIV) who had CD4+ cell counts of either 50 to 299 per cubic millimeter (SILCAAT) or 300 or more per cubic millimeter (ESPRIT) were randomly assigned to receive interleukin-2 plus antiretroviral therapy or antiretroviral therapy alone. The interleukin-2 regimen consisted of cycles of 5 consecutive days each, administered at 8-week intervals. The SILCAAT study involved six cycles and a dose of 4.5 million IU of interleukin-2 twice daily; ESPRIT involved three cycles and a dose of 7.5 million IU twice daily. Additional cycles were recommended to maintain the CD4+ cell count above predefined target levels. The primary end point of both studies was opportunistic disease or death from any cause. RESULTS In the SILCAAT study, 1695 patients (849 receiving interleukin-2 plus antiretroviral therapy and 846 receiving antiretroviral therapy alone) who had a median CD4+ cell count of 202 cells per cubic millimeter were enrolled; in ESPRIT, 4111 patients (2071 receiving interleukin-2 plus antiretroviral therapy and 2040 receiving antiretroviral therapy alone) who had a median CD4+ cell count of 457 cells per cubic millimeter were enrolled. Over a median follow-up period of 7 to 8 years, the CD4+ cell count was higher in the interleukin-2 group than in the group receiving antiretroviral therapy alone--by 53 and 159 cells per cubic millimeter, on average, in the SILCAAT study and ESPRIT, respectively. Hazard ratios for opportunistic disease or death from any cause with interleukin-2 plus antiretroviral therapy (vs. antiretroviral therapy alone) were 0.91 (95% confidence interval [CI], 0.70 to 1.18; P=0.47) in the SILCAAT study and 0.94 (95% CI, 0.75 to 1.16; P=0.55) in ESPRIT. The hazard ratios for death from any cause and for grade 4 clinical events were 1.06 (P=0.73) and 1.10 (P=0.35), respectively, in the SILCAAT study and 0.90 (P=0.42) and 1.23 (P=0.003), respectively, in ESPRIT. CONCLUSIONS Despite a substantial and sustained increase in the CD4+ cell count, as compared with antiretroviral therapy alone, interleukin-2 plus antiretroviral therapy yielded no clinical benefit in either study. (ClinicalTrials.gov numbers, NCT00004978 [ESPRIT] and NCT00013611 [SILCAAT study].
    • 

    corecore